| ||||||||
| ||||||||
| Site Group Page (References Reporting High Throughput Detection Method) |
| Site Information | ||||||||||||||||||||
|
||||||||||||||||||||
| References | ||
|
Kim W, et al. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44, 325-40
21906983 Curated Info |
|
|
Wagner SA, et al. (2011) A Proteome-wide, Quantitative Survey of In Vivo Ubiquitylation Sites Reveals Widespread Regulatory Roles. Mol Cell Proteomics 10, M111.013284
21890473 Curated Info |
|
|
(2010) CST Curation Set: 10369; Year: 2010; Biosample: RPMI-8266; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10368; Year: 2010; Biosample: RPMI-8266; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10367; Year: 2010; Biosample: L363; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10366; Year: 2010; Biosample: L363; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10260; Year: 2010; Biosample: L363; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10261; Year: 2010; Biosample: L363; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10262; Year: 2010; Biosample: RPMI-8266; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10263; Year: 2010; Biosample: RPMI-8266; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8633; Year: 2009; Biosample: AMO-1; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8587; Year: 2010; Biosample: PC3; Disease: prostate cancer; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2009) CST Curation Set: 8582; Year: 2010; Biosample: PC3; Disease: prostate cancer; Treatment: AAG; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2009) CST Curation Set: 8242; Year: 2010; Biosample: LNCaP; Disease: prostate cancer; Treatment: AAG; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2009) CST Curation Set: 6588; Year: 2009; Biosample: U266; Disease: multiple myeloma; Treatment: MG132; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|